Veerle Stouten

853 total citations
43 papers, 385 citations indexed

About

Veerle Stouten is a scholar working on Rheumatology, Hematology and Infectious Diseases. According to data from OpenAlex, Veerle Stouten has authored 43 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Rheumatology, 12 papers in Hematology and 8 papers in Infectious Diseases. Recurrent topics in Veerle Stouten's work include Rheumatoid Arthritis Research and Therapies (29 papers), Autoimmune and Inflammatory Disorders Research (12 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Veerle Stouten is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (29 papers), Autoimmune and Inflammatory Disorders Research (12 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Veerle Stouten collaborates with scholars based in Belgium, Netherlands and United States. Veerle Stouten's co-authors include René Westhovens, Diederik De Cock, Patrick Verschueren, Sofia Pazmiño, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Joris Adriaan Frank van Loenhout, Lucy Catteau and Ruben Brondeel and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of Epidemiology & Community Health and Vaccine.

In The Last Decade

Veerle Stouten

39 papers receiving 380 citations

Peers

Countries citing papers authored by Veerle Stouten

Since Specialization

Citations

This map shows the geographic impact of Veerle Stouten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veerle Stouten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veerle Stouten more than expected).

Fields of papers citing papers by Veerle Stouten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veerle Stouten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veerle Stouten. The network helps show where Veerle Stouten may publish in the future.

Co-authorship network of co-authors of Veerle Stouten

This figure shows the co-authorship network connecting the top 25 collaborators of Veerle Stouten. A scholar is included among the top collaborators of Veerle Stouten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veerle Stouten. Veerle Stouten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Is equitable priority vaccination of vulnerable people feasible in a real-world context? The case of Belgium 2025 ·European Journal of Public Health ·(unknown), (unknown), Veerle Stouten, Christophe Crombez, (unknown), Joris Adriaan Frank van Loenhout	0
2	Area and individual level analyses of demographic and socio-economic disparities in COVID-19 vaccination uptake in Belgium 2024 ·Vaccine X ·(unknown), Laura Van den Borre, Toon Braeye, (unknown), (unknown), Veerle Stouten, (unknown), (unknown), (unknown), Brecht Devleesschauwer, Lucy Catteau, Joris Adriaan Frank van Loenhout	2
3	Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022 2023 ·Vaccine ·Toon Braeye, Lucy Catteau, Ruben Brondeel, Joris Adriaan Frank van Loenhout, (unknown), Laura Cornelissen, Herman Van Oyen, Veerle Stouten, (unknown), (unknown), (unknown), Romain Mahieu, Naïma Hammami, Dieter Van Cauteren, Chloé Wyndham-Thomas	26
4	POS0327 SPEED OF RESPONSE MATTERS: POST-HOC ANALYSIS OF PATIENTS WITH EARLY SERONEGATIVE RHEUMATOID ARTHRITIS INCLUDED IN THE CARERA TRIAL 2023 ·Annals of the Rheumatic Diseases ·Sofia Pazmiño, René Westhovens, Veerle Stouten, Delphine Bertrand, (unknown), Johan Joly, (unknown), (unknown), Patrick Verschueren	0
5	Sociodemographic and socioeconomic disparities in COVID-19 vaccine uptake in Belgium: a nationwide record linkage study 2023 ·Journal of Epidemiology & Community Health ·(unknown), Joris Adriaan Frank van Loenhout, Brecht Devleesschauwer, Chloé Wyndham-Thomas, Herman Van Oyen, (unknown), Koen Blot, Laura Van den Borre, (unknown), Niko Speybroeck, Robby De Pauw, Veerle Stouten, Lucy Catteau, (unknown)	11
6	Factors underlying COVID-19 booster vaccine uptake among adults in Belgium 2023 ·BMC Research Notes ·(unknown), Joris Adriaan Frank van Loenhout, (unknown), Veerle Stouten, (unknown), (unknown), Lucy Catteau, (unknown)	4
7	Patient–physician discordance impairs outcomes in early rheumatoid arthritis through less consistent treat-to-target implementation 2023 ·Lara D. Veeken ·(unknown), Veerle Stouten, Sofia Pazmiño, (unknown), Delphine Bertrand, Johan Joly, René Westhovens, Patrick Verschueren	2
8	COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022 2023 ·Eurosurveillance ·Toon Braeye, Joris Adriaan Frank van Loenhout, Ruben Brondeel, Veerle Stouten, (unknown), (unknown), Pui Yan Jenny Chung, (unknown), Chloé Wyndham-Thomas, Koen Blot, Lucy Catteau	10
9	New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritis 2022 ·Lara D. Veeken ·Sofia Pazmiño, Anikó Lovik, Annelies Boonen, Diederik De Cock, Veerle Stouten, Johan Joly, (unknown), Delphine Bertrand, René Westhovens, Patrick Verschueren	8
10	Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021 2022 ·Vaccine ·Toon Braeye, Lucy Catteau, Ruben Brondeel, Joris Adriaan Frank van Loenhout, (unknown), Laura Cornelissen, Herman Van Oyen, Veerle Stouten, (unknown), (unknown), (unknown), Romain Mahieu, Naïma Hammami, Dieter Van Cauteren, Chloé Wyndham-Thomas	15
11	POS1434 WHICH PROGNOSTIC FACTORS MIGHT PREDICT THE NEED FOR TREATMENT ADAPTATION IN EARLY RHEUMATOID ARTHRITIS? A COMPARISON OF MACHINE LEARNING, SURVIVAL ANALYSIS AND REGRESSION METHODS 2021 ·Annals of the Rheumatic Diseases ·(unknown), Tim Verdonck, Sofia Pazmiño, Veerle Stouten, Delphine Bertrand, (unknown), René Westhovens, Patrick Verschueren, Diederik De Cock	1
12	Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial 2021 ·Annals of the Rheumatic Diseases ·Veerle Stouten, René Westhovens, Sofia Pazmiño, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren	21
13	Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCT 2020 ·Clinical Rheumatology ·Veerle Stouten, (unknown), René Westhovens, Diederik De Cock, (unknown), Sofia Pazmiño, Kristien Van der Elst, Johan Joly, Patrick Verschueren	1
14	Graded response model fit, measurement invariance and (comparative) precision of the Dutch-Flemish PROMIS® Upper Extremity V2.0 item bank in patients with upper extremity disorders 2020 ·BMC Musculoskeletal Disorders ·(unknown), (unknown), (unknown), Derek F.P. van Deurzen, Kristien Van der Elst, Veerle Stouten, Aaron J. Kaat, Leo D. Roorda, Caroline B. Terwee	15
15	THU0093 EARLY REMISSION IS ASSOCIATED WITH LOWER FATIGUE LEVELS ON THE LONG TERM IN PATIENTS WITH RECENT ONSET RHEUMATOID ARTHRITIS 2020 ·Annals of the Rheumatic Diseases ·Diederik De Cock, (unknown), Delphine Bertrand, Veerle Stouten, Sofia Pazmiño, Johan Joly, René Westhovens, Patrick Verschueren	1
16	Does Including Pain, Fatigue, and Physical Function When Assessing Patients with Early Rheumatoid Arthritis Provide a Comprehensive Picture of Disease Burden? 2020 ·The Journal of Rheumatology ·Sofia Pazmiño, Anikó Lovik, Annelies Boonen, Diederik De Cock, Veerle Stouten, Johan Joly, Delphine Bertrand, Kristien Van der Elst, René Westhovens, Patrick Verschueren	9
17	One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatment 2020 ·RMD Open ·Kristien Van der Elst, Patrick Verschueren, Diederik De Cock, An De Groef, Veerle Stouten, Sofia Pazmiño, Johanna E Vriezekolk, Johan Joly, Philip Moons, René Westhovens	24
18	A systematic review on the effect of DMARDs on fertility in rheumatoid arthritis 2020 ·Seminars in Arthritis and Rheumatism ·Diederik De Cock, (unknown), (unknown), Sofia Pazmiño, Delphine Bertrand, Veerle Stouten, René Westhovens, Patrick Verschueren	15
19	Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial 2020 ·Annals of the Rheumatic Diseases ·Sofia Pazmiño, Annelies Boonen, Veerle Stouten, Diederik De Cock, Johan Joly, Kristien Van der Elst, René Westhovens, Patrick Verschueren	14
20	OP0226 Sustained effectiveness of methotrexate with step-down glucocorticoid remission induction (cobra slim) for early rheumatoid arthritis in a treat-to- target setting: 2-year results of the carera trial 2017 ·Annals of the Rheumatic Diseases ·Veerle Stouten, Johan Joly, Diederik De Cock, Sofia Pazmiño, Kristien Van der Elst, René Westhovens, Patrick Verschueren	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact